RAPGEF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.731000E-01
Normal-vs-Stage2
3.231600E-01
Normal-vs-Stage3
2.292400E-01
Normal-vs-Stage4
1.697600E-01
Stage1-vs-Stage2
4.047800E-01
Stage1-vs-Stage3
4.408200E-01
Stage1-vs-Stage4
8.560400E-01
Stage2-vs-Stage3
1.741980E-01
Stage2-vs-Stage4
6.253600E-01
Stage3-vs-Stage4
4.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.110400E-01
Normal-vs-AfricanAmerican
3.358000E-01
Normal-vs-Asian
2.705400E-01
Caucasian-vs-AfricanAmerican
8.535700E-02
Caucasian-vs-Asian
3.240000E-01
AfricanAmerican-vs-Asian
1.115250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.046800E-01
Normal-vs-Female
3.291400E-01
Male-vs-Female
3.429000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.039600E-01
Normal-vs-Age(41-60Yrs)
3.745000E-01
Normal-vs-Age(61-80Yrs)
2.952600E-01
Normal-vs-Age(81-100Yrs)
2.759400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.202000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.137600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.160200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.603400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.462100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.129800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.902200E-01
Normal-vs-Daily Drinker
2.880600E-01
Normal-vs-Weekly Drinker
2.986400E-01
Normal-vs-Occasional Drinker
2.946200E-01
Normal-vs-Social Drinker
3.953800E-01
Non Drinker-vs-Daily Drinker
9.870600E-01
Non Drinker-vs-Weekly Drinker
8.841000E-01
Non Drinker-vs-Occasional Drinker
9.347600E-01
Non Drinker-vs-Social Drinker
1.271800E-01
Daily Drinker-vs-Weekly Drinker
8.399600E-01
Daily Drinker-vs-Occasional Drinker
9.084200E-01
Daily Drinker-vs-Social Drinker
5.946400E-02
Weekly Drinker-vs-Occasional Drinker
9.385800E-01
Weekly Drinker-vs-Social Drinker
1.338190E-01
Occasional Drinker-vs-Social Drinker
1.168350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.351200E-01
Normal-vs-Grade 2
7.414600E-01
Normal-vs-Grade 3
3.652800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.610000E-01
Grade 1-vs-Grade 3
9.959200E-01
Grade 1-vs-Grade 4
5.351200E-01
Grade 2-vs-Grade 3
9.283600E-01
Grade 2-vs-Grade 4
7.414600E-01
Grade 3-vs-Grade 4
3.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.164000E-01
Normal-vs-NonDiabetic
2.994400E-01
Diabetic-vs-NonDiabetic
6.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.355600E-01
Normal-vs-NoPancreatitis
3.046800E-01
Pancreatitis-vs-NoPancreatitis
6.197000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.031800E-01
Normal-vs-N1
3.223200E-01
N0-vs-N1
4.845200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.627620E-01
Normal-vs-TP53-NonMutant
2.178600E-01
TP53-Mutant-vs-TP53-NonMutant
2.676200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
